Introduction: This study aimed to determine the effect and clinical impact of physiological characteristics on the 95th/5th centile of the umbilical artery (UA) Doppler and the cerebroplacental ratio (CPR), at 36+ weeks. Methods: From the multicenter randomized trial “Ratio37,” we selected 4,505 low-risk pregnant women between June 2016 and January 2020. We registered physiological characteristics and the pulsatility indexes (PI) of the UA and middle cerebral artery (36–39 weeks). The 95th/5th centile of the UA PI and CPR was modeled by quantile regression. To evaluate the clinical impact of adjusting Doppler, we retrospectively applied gestational age (GA) and fully adjusted standards to 682 small for gestational age (SGA)-suspected fetuses (37 weeks) from a cohort of consecutive patients obtained between January 2010 and January 2020. Results: Several physiological characteristics significantly influenced the 95th/5th centile of the UA and CPR PI. The fully adjusted 95th centile of the UA was higher, and the 5th centile of the CPR was lower than GA-only-adjusted standards. Of the 682 SGA fetuses, 150 (22%) were classified as late fetal growth restricted only by GA and 112 (16.4%) when we adjusted Doppler. These 38 fetuses had similar perinatal outcome than the SGA group. Discussion: The 95th/5th centile of the UA and CPR PI is significantly influenced by physiological characteristics. Adjusting Doppler standards could differentiate better between FGR and SGA.

1.
Bhide
A
,
Acharya
G
,
Bilardo
CM
,
Brezinka
C
,
Cafici
D
,
Hernandez-Andrade
E
,
ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics
.
Ultrasound Obstet Gynecol
.
2013
;
41
:
233
9
.
2.
Gordijn
SJ
,
Beune
IM
,
Thilaganathan
B
,
Papageorghiou
A
,
Baschat
AA
,
Baker
PN
,
Consensus definition of fetal growth restriction: a Delphi procedure
.
Ultrasound Obstet Gynecol
.
2016
;
48
:
333
9
. .
3.
Baschat
AA
,
Gembruch
U
.
The cerebroplacental Doppler ratio revisited
.
Ultrasound Obstet Gynecol
.
2003
;
21
(
2
):
124
.
4.
Morales-Roselló
J
,
Khalil
A
,
Morlando
M
,
Hervás-Marín
D
,
Perales-Marín
A
.
Doppler reference values of the fetal vertebral and middle cerebral arteries, at 19–41 weeks gestation
.
J Matern Neonatal Med
.
2015
;
28
(
3
):
338
.
5.
Ebbing
C
,
Rasmussen
S
,
Kiserud
T
.
Middle cerebral artery blood flow velocities and pulsatility index and the cerebroplacental pulsatility ratio: longitudinal reference ranges and terms for serial measurements
.
Ultrasound Obstet Gynecol
.
2007
;
30
(
3
):
287
.
6.
Kurmanavicius
J
,
Florio
I
,
Wisser
J
,
Hebisch
G
,
Zimmermann
R
,
Müller
R
,
Reference resistance indices of the umbilical, fetal middle cerebral and uterine arteries at 24–42 weeks of gestation
.
Ultrasound Obstet Gynecol
.
1997
;
10
(
2
):
112
.
7.
Ciobanu
A
,
Wright
A
,
Syngelaki
A
,
Wright
D
,
Akolekar
R
,
Nicolaides
KH
.
Fetal medicine foundation reference ranges for umbilical artery and middle cerebral artery pulsatility index and cerebroplacental ratio
.
Ultrasound Obstet Gynecol
.
2019
;
53
:
465
72
. .
8.
Oros
D
,
Ruiz-Martinez
S
,
Staines-Urias
E
,
Conde-Agudelo
A
,
Villar
J
,
Fabre
E
,
Reference ranges for Doppler indices of umbilical and middle cerebral arteries and cerebroplacental ratio: a systematic review
.
Ultrasound Obstet Gynecol
.
2018
;
53
(
4
):
454
.
9.
Ruiz-Martinez
S
,
Papageorghiou
AT
,
Staines-Urias
E
,
Villar
J
,
Gonzalez De Agüero
R
,
Oros
D
.
Clinical impact of Doppler reference charts on management of small-for-gestational-age fetuses: need for standardization
.
Ultrasound Obstet Gynecol
.
2020 Aug
;
56
(
2
):
166
.
10.
Rial-Crestelo
M
,
Garcia-Otero
L
,
Cancemi
A
,
Giannone
M
,
Escazzocchio
E
,
Biterna
A
,
Prescriptive reference standards of third-trimester cerebroplacental ratio and its physiological determinants
.
Fetal Diagn Ther
.
2020
:
1
.
11.
Lees
CC
,
Stampalija
T
,
Baschat
A
,
da Silva Costa
F
,
Ferrazzi
E
,
Figueras
F
,
ISUOG practice guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction
.
Ultrasound Obstet Gynecol
.
2020
;
56
(
2
):
298
.
12.
Figueras
F
,
Gratacos
E
,
Rial
M
,
Gull
I
,
Eran
A
,
Kacerovsky
M
,
Revealed versus concealed criteria for placental insufficiency in an unselected obstetric population in late pregnancy (RATIO37): randomised controlled trial study protocol
.
BMJ Open
.
2017
;
7
:
e014835
.
13.
Figueras
F
,
Meler
E
,
Iraola
A
,
Eixarch
E
,
Coll
O
,
Figueras
J
,
Customized birthweight standards for a Spanish population
.
Eur J Obstet Gynecol Reprod Biol
.
2008
;
136
:
20
4
. .
14.
Robinson
HP
.
Sonar measurement of fetal crown-rump length as means of assessing maturity in first trimester of pregnancy
.
Br Med J
.
1973
;
4
(
5883
):
28
.
15.
Hadlock
FP
,
Harrist
RB
,
Sharman
RS
,
Deter
RL
,
Park
SK
.
Estimation of fetal weight with the use of head, body, and femur measurements: a prospective study
.
Am J Obstet Gynecol
.
1985
;
151
(
3
):
333
.
16.
Meler
E
,
Mazarico
E
,
Eixarch
E
,
Gonzalez
A
,
Peguero
A
,
Martinez
J
,
A 10 year experience of protocol based management of fetal growth restriction: perinatal outcomes in late pregnancy cases diagnosed after 32 weeks
.
Ultrasound Obstet Gynecol
.
2020
;
57
(
1
):
62
.
17.
Ruiz-Martinez
S
,
Volpe
G
,
Vannuccini
S
,
Cavallaro
A
,
Impey
L
.
An objective scoring method to evaluate image quality of middle cerebral artery Doppler
.
J Matern Neonatal Med
.
2018
:
1
6
.
18.
Rial-Crestelo
M
,
Morales-Roselló
J
,
Hernández-Andrade
E
,
Prefumo
F
,
Oros
D
,
Caffici
D
,
Quality assessment of fetal middle cerebral and umbilical artery Doppler images using an objective scale within an international randomized controlled trial
.
Ultrasound Obstet Gynecol
.
2020
;
56
(
2
):
182
.
19.
Wei
Y
,
Pere
A
,
Koenker
R
,
He
X
.
Quantile regression methods for reference growth charts
.
Stat Med
.
2006
;
25
:
1369
82
. .
20.
Koenker
R
,
Machado
JAF
.
Goodness of fit and related inference processes for quantile regression
.
J Am Stat Assoc
.
1999
.
21.
Gordijn
SJ
,
Beune
IM
,
Thilaganathan
B
,
Papageorghiou
A
,
Baschat
AA
,
Baker
PN
,
Consensus definition of fetal growth restriction: a Delphi procedure
.
Ultrasound Obstet Gynecol
.
2016
;
48
(
3
):
333
.
22.
McCowan
LM
,
Figueras
F
,
Anderson
NH
.
Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy
.
Am J Obstet Gynecol
.
2018
;
218
:
S855
68
. .
23.
Veglia
M
,
Cavallaro
A
,
Papageorghiou
A
,
Small-for-gestational-age babies after 37 weeks: impact study of risk-stratification protocol
.
Ultrasound Obstet Gynecol
.
2018
;
52
(
1
):
66
.
24.
Vinayagam
D
,
Thilaganathan
B
,
Stirrup
O
,
Mantovani
E
,
Khalil
A
.
Maternal hemodynamics in normal pregnancy: reference ranges and role of maternal characteristics
.
Ultrasound Obstet Gynecol
.
2018
;
51
(
5
):
665
.
25.
Lee
Y
,
Magnus
P
.
Maternal and paternal height and the risk of preeclampsia
.
Hypertension
.
2018
.
26.
Widnes
C
,
Flo
K
,
Wilsgaard
T
,
Kiserud
T
,
Acharya
G
.
Sex differences in umbilical artery Doppler indices: a longitudinal study
.
Biol Sex Differ
.
2018
;
9
:
16
. .
27.
Sykes
SD
,
Pringle
KG
,
Zhou
A
,
Dekker
GA
,
Roberts
CT
,
Lumbers
ER
.
The balance between human maternal plasma angiotensin II and angiotensin 1–7 levels in early gestation pregnancy is influenced by fetal sex
.
J Renin Angiotensin Aldosterone Syst
.
2014
;
15
:
523
31
. .
28.
Martinez-Portilla
RJ
,
Caradeux
J
,
Meler
E
,
Lip-Sosa
DL
,
Sotiriadis
A
,
Figueras
F
.
Third-trimester uterine artery Doppler for prediction of adverse outcome in late small-for-gestational-age fetuses: systematic review and meta-analysis
.
Ultrasound Obstet Gynecol
.
2020
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.